NCT00367120已完成4 期
A Multicenter, Randomized, Open Label Comparative Study Of Azithromycin Extended Release (ZMAX) Versus Amoxicillin/Clavulanate Potassium In Subjects With Acute Bacterial Sinusitis (ABS) In A Physician Practice Environment
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 762
- 主要终点
- Patient reported symptom resolution at day 5
研究概览
简要总结
This study will enroll patients with Bacterial Sinusitis who will be treated with either Zmax (Azithromycin Extended Release) or Augmentin (Amoxicillin/Clavulanate). The purpose of the study is to compare early resolution of symptoms between the two treatments. Patients will report resolution of their sinusitis symptoms through a daily questionnaire. There will be two follow-up telephone interviews on days 12 and 28 to evaluate quality of life, satisfaction with therapy, and use of healthcare services.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •A clinical diagnosis of acute uncomplicated bacterial maxillary sinusitis as demonstrated by presence of the following cardinal signs and symptoms for a minimum duration of 7 days, and no longer than 30 days:
- •Facial pain, pressure and/or tightness over one or both maxillary sinuses, and/or pain in one or both maxillary areas that worsens with movement or percussion, and
- •Presence of one or more of the following signs:
- •Discolored (yellow-green) nasal discharge
- •Discolored (yellow-green) drainage in the posterior pharynx
- •Discolored (yellow-green) discharge from the maxillary sinus orifice
- •Two or more of the following symptoms are present:
- •Fever, as defined by:
- •Oral temperature: >38C or >100.4F, or
- •Tympanic temperature: >38.5C or >101.2F
- •Frequent coughing
- •Nasal congestion,
- •Post-nasal drainage.
排除标准
- •Treatment with any systemic antibiotic within 30 days prior to enrollment
- •Symptoms of sinusitis lasting for longer than 30 days;
- •Four or more episodes of acute sinusitis within the preceding 12 months;
结局指标
主要结局
Patient reported symptom resolution at day 5
次要结局
- Time to symptom resolution.
研究者
相似试验
终止
2 期
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636)BlepharitisNCT01269658Merck Sharp & Dohme LLC40
已完成
4 期
Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/ClavulanateSinusitisNCT02340000Albany Medical College315
已完成
4 期
Multicenter, Open, Randomized Comparative Trial To Compare The Efficacy Of Azithromycin Versus Amoxicillin In Children With Strep ThroatTonsillitisNCT00643539Pfizer360
已完成
4 期
Zithromax EV in Community-Acquired Pneumonia (CAP)PneumoniaNCT00137007Pfizer151
已完成
3 期
A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2)COVID-19NCT04381962University of Oxford298